skip to main content
Primo Search
Search in: Busca Geral

Precore/basal core promoter mutants quantification throughout phases of hepatitis B virus infection by Simpleprobe

Tu, Wen-Hui ; Lv, Ying ; Zhang, Yong-Mei ; Hou, Wei ; Wang, Jin-Yu ; Zhang, Yi-Jun ; Liu, Hong-Yan ; Zhu, Hao-Xiang ; Qin, Yan-Li ; Mao, Ri-Cheng ; Zhang, Ji-Ming

World journal of gastroenterology : WJG, 2015-06, Vol.21 (21), p.6639-6648

United States: Baishideng Publishing Group Inc

Texto completo disponível

Citações Citado por
  • Título:
    Precore/basal core promoter mutants quantification throughout phases of hepatitis B virus infection by Simpleprobe
  • Autor: Tu, Wen-Hui ; Lv, Ying ; Zhang, Yong-Mei ; Hou, Wei ; Wang, Jin-Yu ; Zhang, Yi-Jun ; Liu, Hong-Yan ; Zhu, Hao-Xiang ; Qin, Yan-Li ; Mao, Ri-Cheng ; Zhang, Ji-Ming
  • Assuntos: Adolescent ; Adult ; Aged ; Biomarkers - blood ; China ; Disease Progression ; DNA Mutational Analysis - methods ; DNA, Viral - blood ; Female ; Genotype ; Hepatitis B - blood ; Hepatitis B - diagnosis ; Hepatitis B - virology ; Hepatitis B Core Antigens - genetics ; Hepatitis B e Antigens - blood ; Hepatitis B virus - genetics ; Hepatitis B virus - growth & development ; Hepatitis B virus - immunology ; Humans ; Linear Models ; Logistic Models ; Male ; Middle Aged ; Mutation ; Phenotype ; Real-Time Polymerase Chain Reaction ; Retrospective Studies ; Retrospective Study ; Viral Core Proteins - genetics ; Viral Load ; Young Adult
  • É parte de: World journal of gastroenterology : WJG, 2015-06, Vol.21 (21), p.6639-6648
  • Notas: ObjectType-Article-1
    SourceType-Scholarly Journals-1
    ObjectType-Feature-2
    content type line 23
    Author contributions: Tu WH and Lv Y contributed equally to this work; Tu WH, Lv Y and Zhang JM designed the study; Tu WH and Lv Y performed the majority of the study; Tu WH and Hou W collected the serum specimens and clinical data; Zhang YM, Wang JY, Zhang YJ, Liu HY, Zhu HX, Qin YL and Mao RC also participated in the experiments; Tu WH, Lv Y and Zhang YM wrote the manuscript; Zhang JM revised the manuscript.
    Correspondence to: Ji-Ming Zhang, MD, Department of Infectious Disease, Huashan Hospital, Fudan University, No. 12 Wulumuqi Zhong Road, Shanghai 200040, China. jmzhang@fudan.edu.cn
    Telephone: +86-21-52888125 Fax: +86-21-62489015
  • Descrição: To investigate precore/basal core promoter (PC/BCP) mutants throughout hepatitis B virus (HBV) infection and to determine their relationship to hepatitis B early antigen (HBeAg) titers. We enrolled 191 patients in various stages of HBV infection at the Huashan Hospital and the Taizhou Municipal Hospital from 2010 to 2012. None of the patients received antiviral therapy. HBV DNA from serum, was quantified by real-time PCR. The HBV genotype was determined by direct sequencing of the S gene. We used the Simpleprobe ultrasensitive quantitative method to detect PC/BCP mutants in each patient. We compared the strain number, percentage, and the changes in PC/BCP mutants in different phases, and analyzed the relationship between PC/BCP mutants and HBeAg by multiple linear regression and logistic regression. Patients with HBV infection (n = 191) were assigned to groups by phase: Immune tolerance (IT) = 55, Immune clearance (IC) = 67, Low-replicative (LR) = 49, and HBeAg-negative hepatitis (ENH) = 20. Of the patients (male, 112; female, 79) enrolled, 122 were HBeAg-positive and 69 were HBeAg-negative. The median age was 33 years (range: 18-78 years). PC and BCP mutation detection rates were 84.82% (162/191) and 96.86% (185/191), respectively. In five HBeAg-negative cases, we detected double mutation G1896A/G1899A. The logarithm value of PC mutant quantities (log10 PC) significantly differed in IT, IC, and LR phases, as well as in the ENH phase (F = 49.350, P < 0.001). The logarithm value of BCP mutant quantities (log10 BCP) also differed during the four phases (F = 25.530, P < 0.001). Log10 PC and log10 BCP values were high in the IT and IC phases, decreased in the LR phase, and increased in the ENH phase, although the absolute value at this point remained lower than that in the IT and IC phases. PC mutant quantity per total viral load (PC%) and BCP mutant quantity per total viral load (BCP%) differed between phases (F = 20.040, P < 0.001; F = 10.830, P < 0.001), with PC% and BCP% gradually increasing in successive phases. HBeAg titers negatively correlated with PC% (Spearman's rho = -0.354, P < 0.001) and BCP% (Spearman's rho = -0.395, P < 0.001). The negative correlation between PC% and HBeAg status was significant (B = -5.281, P = 0.001), but there was no such correlation between BCP% and HBeAg status (B = -0.523, P = 0.552). PC/BCP mutants become predominant in a dynamic and continuous process. Log10 PC, log10 BCP, PC% and BCP% might be combined to evaluate disease progression. PC% determines HBeAg status.
  • Editor: United States: Baishideng Publishing Group Inc
  • Idioma: Inglês

Buscando em bases de dados remotas. Favor aguardar.